Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Recruiting now · Phase 4 · Has a placebo group
Conditions studied: Coronary Microvascular Disease
In brief
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Key facts
- Study ID
- NCT06699420
- Run by
- Qilu Hospital of Shandong University
- People needed
- 162
- Starts
- 2023-11-08
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2024-11-21
Who can join
Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Repeated chest pain attacks with typical exertional angina pectoris or resting angina pectoris attacks;
- Coronary normal or stenosis < 20%;
- Ischemic depression in ST segment during resting or exercise;
- Blood flow reserve (CFR) of the anterior descending coronary artery < 2.0;
- Subjects or their guardians agreed to participate in this study.
You may not qualify if…
- Previous myocardial infarction or PCI or CABG treatment;
- A history of heart failure;
- Severe arrhythmia;
- Refractory hypertension or hypertension accompanied by left ventricular wall thickness > 12 mm;
- Familial hypercholesterolemia;
- Takayasu arteritis, Kawasaki disease or coronary artery malformation;
- Pregnant or nursing, or having the intention to give birth within one year;
- Hepatic or renal dysfunction;
- Allergic to contrast agents or traditional Chinese medicines;
- Patients who participated in clinical research of other drugs within 3 months before being selected.
Where it is running
- Qilu Hospital of Shandong University — Jinan, Shandong, China (enrolling)
- Jinan Central Hospital Affiliated to Shandong First Medical University — Jinan, Shandong, China (enrolling)
- Qianfoshan Hospital, Shandong University — Jinan, Shandong, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.